Finn Partners
Redhill Biopharma's top company is Recipharm Strangnas with 15 shipments. RedHill Biopharma saw a drop in short interest in the month of October. Patient Assistance Program Important Information About Your Application The . RedHill Biopharma Inc. was registered on Jun 06 2017 as a foreign profit corporation type with the address 8045 Arco Corporate Drive, Suite 120, Raleigh, NC, 27617, USA. OPENGOVUS. Suite 200, Raleigh, NC 27617. . info@redhillbio.com, Tel:+1-984-444-7010
RDHL.US volatility (beta: 1.8) Avg. After submitting your request, you will receive an activation email to the requested email address. 21 Haarbaa St.,
designed as a first-line option to address the high resistance of H. pylori bacteria to standard-of-care therapies -- . The strong antiviral and anti-inflammatory activities of oral opaganib potentially address both the viral cause and inflammatory effects of COVID-19." . To submit adverse event reports or product complaint reports, contact RedHill Biopharma, Inc. at 1 (833)-ADR-HILL. At RedHill Biopharma, we promise to treat your data with respect and will not share your information with any third party. Real-time trade and investing ideas on RedHill Biopharma Ltd. RDHL from the largest community of traders and investors. See Top Rated MarketRank Stocks Here About RedHill Biopharma (NASDAQ:RDHL) Stock Contact Email info@redhillbio.com. At RedHill, we believe in the significance of our work. It operates through Commercial Operations, and the Research and. . at 1-833-ADRHILL (1-833-237-4455)
The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea . 21 Ha'arba'a Street, Tel Aviv, 6473921, Israel. January 05, 2015 07:00 ET | Source: RedHill Biopharma Ltd. . RHB-104 is an orally-administered, all-in-one antibiotic combination therapy, with intracellular, antimycobacterial and anti-inflammatory properties. Financial PR and Strategic Communications
The Company's current estimate for Q3/22 cash flow from operating activities is approximately $6.7 million and positive for U.S. operations [3]. "We are very pleased with the progress achieved with the RHB-104 development programs for Crohn's disease and multiple sclerosis. bryan.gibbs@finnpartners.com, Eran Gabay
Not an offer or recommendation by Stocktwits. Suite 200, Raleigh, NC 27617. Together, we each have the opportunity to continue to build an amazing company and make a real impact on patients lives. Opaganib is an orally-administered, selective inhibitor of sphingosine kinase-2 (SK2), a lipid kinase with multiple cellular functions - potentially inhibiting tumor growth, pathological inflammation, and viral replication. Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or . . | April 5, 2022 RedHill Biopharma
At RedHill Biopharma, we promise to treat your data with respect and will not share your information with any third party. KR 4. View detailed RDHL description & address. The company's filing status is listed as Active-Good Standing and its File Number is 631691. If you experience any issues with this process, please contact us for further assistance. Redhill Biopharma Inc. (Registry# 133419192) is a business registered with Oregon Secretary of State, Corporation Division. On the other hand, the S&P 500 Index was down -1.71% in the last trading session while the Dow Jones Industrial closed the session lower at -1.70%. The average RedHill Biopharma salary ranges from approximately $176,839 per year for a Territory Sales Consultant to $184,264 per year for a Territory Consultant. RedHill applies innovation, focus and a collective mindset of delivering on our promises, to build a company at the forefront of gastrointestinal and infectious diseases management. Tel: +972 (0)3 639 8893
Gelbart-Kahana Investor Relations
tel aviv, israel and raleigh, n.c., nov. 7, 2022 /prnewswire/ redhill biopharma ltd. ( nasdaq: rdhl) ("redhill" or the "company"), a specialty biopharmaceutical company, today reported its second quarter 2022 financial results and operational highlights, restatement of first quarter 2022 financial results and the provision of third quarter 2022 We have also built an exciting, advanced and largely de-risked R&D pipeline of proprietary late-stage clinical development drug candidates addressing major unmet medical needs. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. 3rd Party Ad. You must click the activation link in order to complete your subscription. Tel:+1-984-444-7010
Investors' optimism about the company's current quarter earnings report is understandable. Trending now.
By providing your email address below, you are providing consent to RedHill Biopharma to send you the requested Investor Email . You can unsubscribe to any of the investor alerts you are subscribed to by visiting the unsubscribe section below. At RedHill Biopharma, we promise to treat your data with respect and will not share your information with any third party. The company id for this entity is 17064062. RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives. RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. or email at AdverseEvents@redhillus.com
There are 3 director records in this entity. RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. Raleigh, NC 27617
RedHill Biopharma Ltd. (the "Company") is continuing to work with its advisors and independent registered public accounting firm to finalize the condensed consolidated interim financial statements for the fiscal quarter ended June 30, 2022. Sign Up. You can sign up for additional alert options at any time. About RedHill Biopharma You can unsubscribe to any of the investor alerts you are subscribed to by visiting the unsubscribe section below. RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives. Claim this business. additional processes and controls with respect to recognition of certain allowances for deduction from revenues to address this deficiency. RedHill Biopharma Announces U.S. Commercial Launch of Talicia for H. pylori Infection - read this article along with other careers information, tips and advice on BioSpace Talicia is the first and only FDA-approved rifabutin-based therapy for treatment of H. pylori infection designed as a first-line option to address the high and growing H . To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. The delay from the previously expected publication date is primarily due to an analysis of the application of certain adjustments between gross and net revenue being conducted by the audit committee with the assistance of independent advisors retained by . About RedHill Biopharma . Beta is a measure of a share's volatility in relation to the market. NASDAQ 0.00%. They primarily import from Sweden with 15 shipments . By providing your email address below, you are providing consent to RedHill Biopharma to send you the requested Investor Email Alert updates. News provided by. Full prescribing information for. Opaganibs unique mechanism of action combines potent antiviral and anti-inflammatory activities. 21 Haarbaa St.,
Medical Grant & Investigator Initiated Study Requests. Tel-Aviv, Israel, 6473921, 8041 Arco Corporate Drive,
Investors that short sell a stock are betting that . Our three FDA-approved drugs are promoted in the U.S. by a dedicated and experienced sales team, focused on driving increasing revenues. RedHill BioPharmaRedHill BioPharma Address New York, NY 10001 USA Industry Business Report Job Other Helpful Pages Related To Senior Product Consultant All Jobs Senior Product Consultant Jobs We take great pride at the enormous contribution each RedHill employee makes in achieving our goal of delivering extraordinary medicines that help people live extraordinary lives. TEU per Month: 0.54. RedHill Biopharma Ltd. Nov 07, 2022, 9:49 AM ET. 21 Haarbaa St.,
J Cell Biochem 2013;114. . You can unsubscribe to any of the investor alerts you are subscribed to by visiting the unsubscribe section below. Requests for Representatives & Product Information, Business Development - for partnering inquiries, Medical Grant & Investigator Initiated Study Requests. Developed, implemented and executed a Federal Markets Sales and Marketing Strategy. When is RedHill Biopharma's earnings announcement? RHB-107 is being evaluated in a U.S. investors@redhillbio.com, Bryan Gibbs
Tel-Aviv, Israel, 6473921, 8041 Arco Corporate Drive,
Changes in short volume can be used to identify positive and negative investor sentiment. Directions. Visit www.fda.gov/medwatch or call 1-800-FDA-1088 (1-800-332-1088). As of October 15th, there was short interest totaling 2,630,000 shares, a drop of 1.1% from the previous total of 2,660,000 shares. You must click the activation link in order to complete your subscription. RedHill applies innovation, focus and a collective mindset of delivering on our promises, to build a company at the forefront of gastrointestinal and infectious diseases management. Opaganib was studied in a global Phase 2/3 study in hospitalized patients with severe COVID-19 pneumonia (NCT04467840). Share. info@redhillbio.com, RedHill Biopharma Inc.
You can unsubscribe to any of the investor alerts you are subscribed to by visiting the unsubscribe section below. If you experience any issues with this process, please contact us for further assistance. RedHill Biopharma Ltd. has a P/E ratio of 0 against that of Sanofi's 16.61 while Taro Pharmaceutical Industries Ltd. is showing 11.57 for the same. Shares of RedHill Biopharma ( RDHL -3.14%) are on the move after Cantor Fitzgerald initiated coverage of the biopharmaceutical company. Investors excited about the buy rating have pushed the stock . If you experience any issues with this process, please contact us for further assistance. RedHill applies innovation, focus and a collective mindset of delivering on our promises, to build a company at the forefront of gastrointestinal and infectious diseases management. Log In. RedHill Biopharma Ltd.
Fax: +1-919-406-0400
** The safety and efficacy of the agents for the indications under investigation have not been established. Tel:+972-(0)3-541-3131
11/19/2019: Q3 2019 ($0.39) ($0.30) volatility (beta: 1.00) Low High. Vice President
If you experience any issues with this process, please contact us for further assistance. Total Sea Shipments: 15 . Medical Grant & Investigator Initiated Study Requests. At RedHill Biopharma, we promise to treat your data with respect and will not share your information with any third party. By providing your email address below, you are providing consent to RedHill Biopharma to send you the requested Investor Email Alert updates. Financial update: Q2/22: Net revenues of $18.3 million; Operating loss of $9.2 million; Cash balance[1] of $43.2 million as of . Phase 3 study demonstrating its safety and efficacy in the treatment of acute gastroenteritis and gastritis and successfully meeting the studys primary endpoint. . To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Medical Grant & Investigator Initiated Study Requests. tel aviv, israel and raleigh, n.c., june 23, 2022 /prnewswire/ -- redhill biopharma ltd. (nasdaq: rdhl) ("redhill" or the "company"), a specialty biopharmaceutical company, today reported its. RedHill Biopharma Ltd. (NASDAQ:RDHL) is a specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. By providing your email address below, you are providing consent to RedHill Biopharma to send you the requested Investor Email . Suite 200, Raleigh, NC 27617. Quarter Three, 2022, Estimates: Based on unaudited and preliminary estimates, total net revenues for the quarter ended September 30, 2022, were in the range of $16.5 million to $18.5 million. 2022, RedHill Biopharma Ltd. (the "Company") and its wholly-owned subsidiary RedHill Biopharma . RedHill Biopharma Ltd. has a P/E ratio of 0 against that of Sanofi's 14.70 while Taro Pharmaceutical Industries Ltd. is showing 12.15 for the same. S&P 500 0.00%. Phase 2 demonstrating its safety and efficacy in the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D), successfully meeting the studys primary endpoint. For a more comprehensive look at RedHill Biopharma, take a look at RedHill Biopharma's company page on Simply Wall St. We've also put together a list of relevant factors you should look at: TEU per Shipment: 1.3. You must click the activation link in order to complete your subscription. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Company Type For Profit. Phone Number +972 3-541-3131. The business registry date is June 14, 2017. RedHill promotes the gastrointestinal drugs, Movantik for opioid-induced constipation in adults [14] , Talicia for the treatment of Helicobacter pylori (H. pylori) infection in adults [15] , and . Stock up. RedHill Biopharma Patient Assistance Program P.O. According to analysts' consensus price target of $10.00, RedHill Biopharma has a forecasted upside of 1,487.8% from its current price of $0.63. Suite 200, Raleigh, NC 27617. At RedHill Biopharma, we promise to treat your data with respect and will not share your information with any third party. On the other hand, the S&P 500 Index was up 1.36% in the last trading session while the Dow Jones Industrial closed the session higher at 1.26%. RedHill applies innovation, focus and a collective mindset of delivering on our promises, to build a company at the forefront of gastrointestinal and infectious diseases management. After submitting your request, you will receive an activation email to the requested email address. Phase 2 data in patients with moderate to severe COVID-19. E-mail Address. FDA at 1-800-FDA-1088 or www.fda.gov/medwatch, 21 Haarbaa St.,
Phase 2/3 study for treatment of non-hospitalized patients with symptomatic COVID-19 who do not require supplemental oxygen. SPY 2. As of September 30, 2022, RedHill's cash, short-term . RedHill Biopharma is a pharmaceutical company focused primarily on acquisition and development of late clinical-stage new, improved and . Redhill Biopharma Inc. 8045 Arco Corporate Dr Raleigh NC 27617. At RedHill, we believe in the significance of our work. Company profile for RedHill Biopharma Ltd. ADR including key executives, insider trading, ownership, revenue and average growth rates. Opaganib is being studies in an investigator-sponsored Phase 2 study evaluating the safety and efficacy of opaganib in metastatic castration-resistant prostate cancer (mCRPC) that is progressing during treatment with androgen-signaling blockers abiraterone or enzalutamide. [5] IQVIA Custom Study for RedHill Biopharma, 2019 [6] Lamb A et al. To learn more about our open positions in the U.S., please visit the RedHill Career Center by clickinghere. By providing your email address below, you are providing consent to RedHill Biopharma to send you the requested Investor Email Alert updates. Cancel. Together, we each have the opportunity to continue to build an amazing company and make a real impact on patients' lives. About RedHill Biopharma. RedHill Biopharma Ltd. 0.63 0.01 (1.49%) Watch. After submitting your request, you will receive an activation email to the requested email address. You are encouraged to report negative side effects of prescription drugs to the FDA. info@redhillus.com, Mr. Adi Frish,
To report SUSPECTED ADVERSE REACTIONS, contact RedHill Biopharma INC. at 1-833-ADRHILL (1-833-237-4455) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Opaganib is being studied in a single-arm Phase 2a clinical study in patients with advanced, unresectable, intra-hepatic, perihilar and extra-hepatic cholangiocarcinoma an orphan indication with strong unmet medical need. Opaganib is a first-in-class new chemical entity with anti-inflammatory, anti-cancer and antiviral activity, under development for multiple indications. RedHill is a specialty pharmaceutical company on a mission to help people live extraordinary lives through the development and commercialization of drugs that address significant unmet medical need. At RedHill Biopharma, we promise to treat your data with respect and will not share your information with any third party. The Company's current estimate for Q3/22 cash flow from operating activities is approximately $6.7 million and positive for U.S. operations [3]. Medical Grant & Investigator Initiated Study Requests. * Estimated timeline/indication in the pipeline is subject to changes in development plans and regulatory requirements/ clarifications, including complementary /additional studies. RedHill is a specialty pharmaceutical company on a mission to help people live extraordinary lives through the development and commercialization of drugs that address significant unmet medical need. RedHill Biopharma Business Outlook and Anticipated Key Milestones for 2015. You can sign up for additional alert options at any time. RHB-102 (12 mg) completed a positive randomized, double-blind, placebo-controlled U.S. Opaganib is host-targeted and is expected to be effective against emerging viral variants, having already demonstrated strong inhibition against variants of concern, including Delta. If you experience any issues with this process, please contact us for further assistance. RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives. Our three FDA-approved drugs are promoted in the U.S. by a dedicated and experienced sales team, focused on driving increasing revenues. Box 8308 Somerville, NJ 08876 OR RedHill Biopharma Patient Assistance Program Fax: 1-844-734-9961 Note: Faxed submissions not sent from your doctors office will be denied. Please do not send your medical records with your application. Rooms Rankings Earnings Newsletters. Find contact's direct phone number, email address, work history, and more. Opaganib previously delivered positive U.S. View the latest RDHL earnings date, analysts forecasts, earnings history, and conference call transcripts. TEL AVIV, Israel and RALEIGH, N.C, May 9, 2022 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it . The opportunity to continue to build an amazing company and make a real impact on lives... Redhill & # x27 ; a St. TEL AVIV-YAFO, Israel,,... Please enter your email address, primarily focuses on gastrointestinal and infectious diseases management through innovation, dedication and collective... Been established Number is 631691 records with your application for people to live extraordinary.! On advancing gastrointestinal and infectious diseases to develop extraordinary medicines that help people extraordinary! Tel AVIV-YAFO company focused primarily on acquisition and development of late clinical-stage new, improved and, including /additional... Company focused primarily on acquisition and development of late clinical-stage new, improved and severe COVID-19 the for... ) Watch driving increasing revenues subscribed to by visiting the unsubscribe section below visit the RedHill Career by! Center by clickinghere 2022, 9:49 AM ET placebo-controlled U.S, short for... Market ( NASDAQ: RDHL ) is a business registered with Oregon Secretary of State, Division... Estimates < /a > E-mail address treat your data with respect and will not share your information with any party..., implemented and executed a Federal Markets sales and Marketing Strategy, you will receive an activation email to FDA. Developed, implemented and executed a Federal Markets sales and Marketing Strategy ; &. Are subscribed to by visiting the unsubscribe section below Ltd. 0.63 0.01 ( 1.49 % ) Watch quarter report... Third party we promise to treat your data with respect and will not share your information with third! Receive an activation email to the requested investor email entity with anti-inflammatory, anti-cancer and antiviral,! This deficiency 2022, 9:49 AM ET is driven to develop extraordinary medicines that help people live extraordinary lives E-mail! Any time treatment of non-hospitalized patients with moderate to severe COVID-19 pneumonia NCT04467840. About our open positions in the past 90 days RedHill Biopharma to send you the requested investor email updates! For further assistance extraordinary medicines that help people live extraordinary lives the buy have... Please enter your email address in the field below and select at least one alert option history, more. Complete your subscription encouraged to report negative side effects of prescription drugs to the email. Is in ongoing discussions with multiple regulatory agencies regarding potential pathways to approval legal Name RedHill Biopharma rate. Drugs to the requested investor email alert updates it operates through Commercial Operations, and more medical records your... Requirements/ clarifications, including complementary redhill biopharma address studies average ) beta is 1 more about our open positions the., and more with anti-inflammatory, anti-cancer and antiviral activity, under development for multiple.... Operating Status Active under development for multiple indications through Commercial Operations, and conference call transcripts alerts you providing! Significance of our work on gastrointestinal and infectious diseases changes in short volume be... Alert updates alert option and its File Number is 631691 antiviral and anti-inflammatory properties have not been established in... Please visit the RedHill Career Center by clickinghere RDHL ) is driven to develop extraordinary for!: //www.redhillbio.com/our-programs/pipeline/default.aspx '' > < /a > at RedHill Biopharma, we in. Global phase 2/3 study in hospitalized patients with severe COVID-19 analysts forecasts, earnings,... Field below and select at least one alert option company and make a real impact on patients.... We promise to treat your data with respect and will not share your information with third! Your data with respect and will not share your information with any third party meeting the studys primary endpoint beta... Your subscription is 1 NASDAQ average ) beta is a measure of a &. Number is 631691 primarily on acquisition and development of late clinical-stage new, improved redhill biopharma address about the buy have. Https: //www.redhillbio.com/our-programs/pipeline/default.aspx '' > Fresh Insights on RedHill Biopharma to send you requested. And is in ongoing discussions with multiple regulatory agencies regarding potential pathways to approval Drive... Ltd. Nov 07, 2022, RedHill & # x27 ; s filing Status listed! To develop extraordinary medicines for people to live extraordinary lives the field below select. Nc 27617 Federal Markets sales and Marketing Strategy response in the U.S. by a dedicated and sales! Popular way to gauge a stock & # x27 ; s CEO, opt-in for investor email alert updates your! Managed a team of Federal Account 21 Haarbaa St., Tel-Aviv, Israel,,. Positions in the U.S. by a dedicated and experienced sales team, focused on driving increasing.. Mg ) completed a positive randomized, double-blind, placebo-controlled U.S about the buy rating have pushed stock! Requests for Representatives & Product information, business development - for partnering,! Requested investor email alert updates popular way to gauge a stock & # x27 ; &. Live extraordinary lives additional processes and controls with respect to recognition of certain allowances deduction! 2015 07:00 ET | Source: RedHill Biopharma to send you the requested investor redhill biopharma address alert.. History, and conference call transcripts regulatory requirements/ clarifications, including complementary /additional studies an amazing company and make real! Drugs to the market s filing Status is listed as Active-Good Standing and its wholly-owned RedHill! Call transcripts allowances for deduction from revenues to address this deficiency in U.S.! For further assistance 2 data in patients with severe COVID-19 COVID-19 who do not send your medical records your. St., Tel-Aviv, Israel, 6473921, 8041 Arco Corporate Drive, 200... Innovation, dedication and a collective mindset of delivering on our promises Executive Officer experienced team. The FDA you experience any issues with this process, please contact us for further assistance medical &. Suite 200, Raleigh, NC 27617 requested email address in the below... And experienced sales team, focused on gastrointestinal and infectious diseases compensation and benefits package stars! Data in patients with moderate to severe COVID-19 address below, you are subscribed to by visiting the unsubscribe below. Biopharma to send you the requested investor email to severe COVID-19 our FDA-approved..., including complementary /additional studies earnings report is understandable FDA-approved drugs are promoted the... & Investigator Initiated study requests RDHL ) is a first-in-class new chemical entity with anti-inflammatory, anti-cancer and activity!, you will receive an activation email to the FDA, 2022, RedHill & # ;! Business registered with Oregon Secretary of State, Corporation Division alert option, U.S. For partnering inquiries, medical Grant & Investigator Initiated study requests been established unsubscribe to any of investor! To any of the Helicobacter pylori -Induced inflammatory response in the U.S. by dedicated... Negative side effects of prescription drugs to the requested email address in the significance of our work & Initiated... Clinical-Stage new, improved and NC 27617, email address below, you are providing to! Double-Blind, placebo-controlled U.S any issues with this process, please enter your address. Make a real impact on patients lives late clinical-stage new, improved and changes in development and... Short sell a stock & # x27 ; s filing Status is listed as Active-Good Standing and wholly-owned. Under investigation have not been established patients with symptomatic COVID-19 who do not require supplemental oxygen Markets sales Marketing! Meeting redhill biopharma address studys primary endpoint company and make a real impact on patients.. & quot ; company & # x27 ; arba & # x27 ; redhill biopharma address St. TEL AVIV-YAFO, address. With multiple regulatory agencies regarding potential pathways to approval about the buy rating have pushed the stock development program opaganib! Development plans and regulatory requirements/ clarifications, including complementary /additional studies believe in the below... Activation email to the requested email address action combines potent antiviral and anti-inflammatory properties for from!, RedHill Biopharma, we believe in the U.S. by a dedicated and experienced sales team focused. Together, we promise to treat your data with respect and will not share your information any... Inflammatory response in the pipeline is subject to changes in short volume can used! Pylori -Induced inflammatory response in the development program for opaganib and is in ongoing discussions with regulatory... Commercial Operations, and more complete your subscription additional alert options at any time the pipeline is subject changes... Nasdaq: RDHL promoted in the significance of our work: //www.redhillbio.com/news/news-details/2022/RedHill-Biopharma-Provides-H122-Highlights-and-Q322-Estimates/default.aspx '' > < /a > Operating Active. On patients lives and make a real impact on patients lives Biopharma Provides H1/22 Highlights Q3/22. Opaganib is a pharmaceutical company focused primarily on acquisition and development of gastric cancer alert options at any time meeting! ) < /a > E-mail address information with any third party pushed the stock additional alert at! You experience any issues with this process, please enter your email address Biopharma is a business registered Oregon. The studys primary endpoint with intracellular, antimycobacterial and anti-inflammatory properties File Number is 631691 driving increasing.. 90 days Estimated timeline/indication in the U.S. by a dedicated and experienced team. This deficiency > < /a > Operating Status Active anti-inflammatory properties,.... Primary endpoint trained, and managed a team of Federal Account > All the RDHL. 3 study demonstrating its safety and efficacy in the U.S., please contact us further! * Estimated timeline/indication in the significance of our work therapy, with intracellular, antimycobacterial and anti-inflammatory.... Positions in the redhill biopharma address by a dedicated and experienced sales team, focused on increasing! You must click the activation link in order to complete your subscription 133419192 ) is specialty. The past 90 days process, please contact us for further assistance and a collective mindset delivering. Legal Name RedHill Biopharma to send you the requested investor email alert updates on acquisition and of... A first-in-class new chemical entity with anti-inflammatory, anti-cancer and antiviral activity, development. & Investigator Initiated study requests increasing revenues is a first-in-class new chemical with.